DrugDashboards

Am-7

Strychnos nux-vomica seed, Sodium Phosphate, Dibasic, Heptahydrate, and BUFO BUFO WHOLE · STRYCHNOS NUX-VOMICA SEED 8 [hp_X]/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 8 [hp_X]/mL; BUFO BUFO WHOLE 12 [hp_X]/mL · Solution · Sublingual · DNA Labs, Inc.

NDC 58264-0346-01 · 29.57 mL in 1 BOTTLE, GLASS · UNAPPROVED HOMEOPATHIC · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Strychnos nux-vomica seed, Sodium Phosphate, Dibasic, Heptahydrate, and BUFO BUFO WHOLE (Solution)

LabelerStrengthFirst seenLast seen
DNA Labs, Inc.STRYCHNOS NUX-VOMICA SEED 8 [hp_X]/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 8 [hp_X]/mL; BUFO BUFO WHOLE 12 [hp_X]/mLAug 26, 2026Sep 2, 2026
DNA Labs, Inc.STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 8 [hp_X]/mL; BUFO BUFO WHOLE 8 [hp_X]/mLJul 22, 2026Aug 19, 2026
DNA Labs, Inc.BUFO BUFO WHOLE 12 [hp_X]/mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 8 [hp_X]/mL; STRYCHNOS NUX-VOMICA SEED 8 [hp_X]/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Am-7 — NDC 58264-0346-01," retrieved September 3, 2026, https://drugdashboards.com/drug/58264034601.

Free to cite with attribution — see how the data is put together.